Best Life Sciences Companies in Queensland, Australia
The 85 best Life Sciences companies in Queensland, Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: QBiotics.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Queensland
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | QBiotics Developer of small molecules discovered from the plant extracts 48Moat top 28%Product top 30%Funding top 35%Talent top 38% All 10 signals ▾Moattop 28% Producttop 30% Fundingtop 35% Talenttop 38% Patentstop 41% Innovationtop 42% Growthtop 45% Marketbottom 42% Globalbottom 42% Techbottom 40% Moat: Editorial + unicorn rating 8/10 · IP moat: 64 patents Product: 3 distinct product lines · Company stage: Series C rank vs industry peers · Fliar Intelligence Index 48/100 | $98M | 59 mo ago | Series C | 58 | 2000 | Paul Reddell Co-Founder | 64 patents Patents concentrated in chemistry & materials | 1 job opening |
| 2 | Vaxxas Developer of a needle-free patch technology for vaccine delivery applications 57News top 17%Funding top 23%Growth top 25%Moat top 39% All 8 signals ▾Newstop 17% Fundingtop 23% Growthtop 25% Moattop 39% Talenttop 45% Markettop 50% Techbottom 36% Globalbottom 36% News: 11 BI events in 12 mo (of 30 tracked, 6 types) · +1000% YoY Funding: Raised $59.3M across 9 rounds · 9 rounds over 15 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 57/100 | $59M | 9 mo ago | Series D | 113 | 2010 | David Peacock CEO | — | — |
| 3 | Science In Sport Brand of sports nutrition and vitamin products | $48M | 22 mo ago | Acquired | 215 | 1992 | — | — | — |
| 4 | EMvision Provider of portable electromagnetic microwave imaging solution | $24M | 27 mo ago | Public | — | 2017 | Scott Kirkland CEO and Managing Director | — | — |
| 5 | Rage Biotech Developer of therapeutics for respiratory diseases | $19M | 7 mo ago | Series A | 6 | 2020 | — | 22 patents Nucleic‑acid therapeutics targeting RAGE for respiratory disease treatment and monitoring | — |
| 6 | AdvanCell Radiopharmaceutical company developing targeted alpha therapies for cancer treatment | $17M | 14 mo ago | Series C | 23 | 2019 | Andrew Adamovich Founder | — | 1 expansion |
| 7 | Kira Biotech Developer of immunomodulatory drugs to treat immune diseases | $14M | 79 mo ago | Series A | 5 | 2019 | — | 22 patents Patents concentrated in chemistry & materials | — |
| 8 | Oventus Developer of medical devices for sleep disorders | $11M | 102 mo ago | Public | 35 | 2011 | — | — | — |
| 9 | Magnetica Developer of magnetic resonance imaging devices for the diagnosis of multiple diseases | $8M | 42 mo ago | Series A | 59 | 2005 | Duncan Stovell Managing Director & CEO | 40 patents Patents concentrated in computing, sensing & instrumentation | 1 job opening |
| 10 | Australis Scientific Developing novel medical products that utilise neural modulation technologies | $6M | 0 mo ago | Series A | — | 2021 | Danielle Delaney Co-Founder | — | 1 internship · 2 partnerships |
| 11 | Paragen Bio Developer of biologics for the treatment of autoimmune diseases | $6M | 94 mo ago | Deadpooled | — | 2017 | Norelle Daly Co-Founder | — | — |
| 12 | WearOptimo Developer of wearable sensor technology for real-time personal health monitoring | $5M | 43 mo ago | Series A | 35 | 2018 | Mark Kendall Founder & Chief Executive Officer | — | — |
| 13 | Ellume Developer of a diagnostic device that uses quantum dot nanoparticles to provide real-time patient testing | $5M | 64 mo ago | Series A | 135 | 2010 | Sean Parsons Founder & MD | 52 patents Fluorescent lateral flow immunoassay devices for rapid point‑of‑care diagnostics | — |
| 14 | Nexgen Plants Provider of platform technology for developing virus-resistant plant varieties | $4M | 94 mo ago | Deadpooled | 2 | 2009 | — | 10 patents Intragenic plant transformation vectors and recombinant DNA constructs for crop genetic improvement. | — |
| 15 | Convergence Medical Developer of robots for arthroscopic surgery | $3M | 17 mo ago | Series A | 2 | 2022 | — | 9 patents Robotic-assisted arthroscopic surgery hardware and control interfaces | — |
| 16 | Microba Developer of microbiome-based drug discovery platform | $3M | 12 mo ago | Public | 72 | 2017 | Gene Tyson Founder & Director | — | — |
| 17 | Analytica eHealth treatment system for stress incontinence | $3M | 122 mo ago | Public | 1 | 1998 | — | 40 patents Patents concentrated in health & consumer products | — |
| 18 | Gelomics Manufacturer of extracellular matrix for research purpose | $2M | 23 mo ago | Seed | 9 | 2018 | Travis Klein Co-Founder | — | — |
| 19 | Cyteph Developer of CAR T cell therapies for the treatment of cancer | $2M | 36 mo ago | Funding Raised | — | 2023 | Rajiv Khanna Founder and CSO | — | — |
| 20 | Jetra Therapeutics Developer of therapeutics for the treatment of metabolic disorders | $1M | 56 mo ago | Seed | 3 | 2019 | — | — | — |
| 21 | Fitgenes Personalised genome-based healthcare and wellness | $1M | 144 mo ago | Late Stage | 6 | 2007 | Paul Beaver Co-Founder & CSO | — | — |
| 22 | Implicit Bioscience Develops therapeutics for infectious diseases | $768K | 69 mo ago | Seed | 11 | 2004 | Garry Redlich CEO & MD | 41 patents Patents concentrated in chemistry & materials | 1 partnership |
| 23 | Augmented Bionics Developer of a non-invasive device to treat hearing loss | $650K | 68 mo ago | Deadpooled | 5 | 2018 | Viraj Agnihotri Founder & CEO | 6 patents Non‑invasive neural sensory stimulation devices for prosthetic feedback and rehabilitation | — |
| 24 | Uira BioenergEthic Developing functional foods and nutraceutical supplements for vegetarian and healthy diets. | $250K | 120 mo ago | Deadpooled | 3 | 2014 | — | — | — |
| 25 | ComWriter Academic writing platform | $250K | 166 mo ago | Seed | — | 2012 | Linda Glassop Founder & CEO | — | — |
| 26 | iOrthotics Developer of 3d printed orthotic products for patients suffering from orthopedic disorders | $195K | 96 mo ago | Seed | — | 2009 | Dean Hartley Co-Founder & Managing Director | — | — |
| 27 | Rapid Nutrition Manufactures and exports nutritional products | $178K | 104 mo ago | Public | 9 | 2001 | Simon St Ledger Founder & CEO | — | — |
Top 12 Life Sciences companies in Queensland
#1
Series D · Brisbane, Queensland · founded 2010 · 113 employees$59.3Mraised▾
Developer of a needle-free patch technology for vaccine delivery applications. The company’s technology uses a patch with microprojections applied to the skin. This approach aims to enhance vaccine efficiency and effectiveness. The company’s dry-coating technology reduces the need for vaccine refrigeration during storage and transport. The company targets applications in infectious disease and oncology.
- Aug 2025Conventional Debt$25.2M
- Aug 2025Series D$31.9M
- Dec 2022Series C$23M
- Sep 2022Grant (prize money)$5.5M
#2
Series A · Fortitude Valley, Queensland · founded 2021$6Mraised▾
Developing novel medical products that utilise neural modulation technologies. Its flagship product, the In Confidence Smart Patch, which aims to provide a discreet solution for both acute and chronic urinary incontinence symptoms.
- Nov 2025Series A$6M
- Oct 2023Seed—
#3
Series A · Melbourne, Queensland · founded 2020 · 6 employees$18.9Mraised▾
Developer of therapeutics for respiratory diseases. These therapies help in modulating the receptor for advanced glycation end-products (RAGE), which is a multi-ligand, transmembrane receptor expressed in the lung. The RAGE is recognized as a mediator of pathological, chronic lung inflammation and has been involved in the lung diseases such as severe asthma, chronic obstructive pulmonary disease, cystic fibrosis, and acute respiratory distress syndrome.
- Nov 2025Series A$18.9M
#4
Series C · Brisbane, Queensland · founded 2019 · 23 employees$17.4Mraised▾
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment. The company involves a proprietary ²¹²Pb production technology that provides access to alpha isotopes to accelerate the clinical development of drugs for prostate, skin, pancreatic, breast, bladder, colorectal, kidney, lung, and ovary cancer.
- Apr 2025Grant (prize money)$18M
- Feb 2025Series C$112M
- Dec 2023Series B$5M
- Aug 2022Series B$12.4M
#5
Acquired · Manly, Queensland · founded 1992 · 215 employees$48.5Mraised▾
Brand of sports nutrition and vitamin products. The company offers vitamins & minerals, Omega 3 fish oils, and supplements for sleep management, gut health, gummies, vitamin D3 products, and more.
- Jul 2024Post IPO$11M
- Nov 2018Post IPO$37.5M
- Feb 2017Angel—
#6
Public · Brisbane, Queensland · founded 2017 · 72 employees$2.9Mraised▾
Developer of microbiome-based drug discovery platform. The company uses human data and leading informatics approaches to connect microbial genotype to the human phenotype. It develops a pipeline for inflammatory bowel disease and Immuno-oncology diseases.
- Jun 2025Post IPO$9.3M
- Jun 2023Grant (prize money)—
- Jun 2019Series A$2.9M
#7
Series A · Brisbane, Queensland · founded 2022 · 2 employees$3.1Mraised▾
Developer of robots for arthroscopic surgery. The company's product includes the V01 an arthroscopic robot to make minimally invasive surgery better.
- Jan 2025Series A$3.1M
#8
Public · Brisbane, Queensland · founded 2017$24Mraised▾
EMvision provides portable electromagnetic microwave imaging solution. The company offers a point-of-care, non-invasive, rapid brain scanner for stroke and brain injury diagnosis and monitoring. Their system provides three-dimensional images of biological tissue with microwave tomography.
- Feb 2024Post IPO$10M
- Oct 2022Grant (prize money)$5M
- Jul 2020Post IPO$9M
#9
Series C · Brisbane, Queensland · founded 2000 · 58 employees$98.1Mraised▾
QBiotics, a subsidiary of Ecobiotics is developing small molecules discovered from the natural product (plant extract of Blushwood) for the human & veterinary application. Their lead molecule, EBC-46 (tigilanol tiglate), a phorbol ester is being targeted for the treatment of solid tumor cancers (proof of concept clinical trials are completed). Its mechanism of action is the protein kinase C (PKC) activator. Another molecule, EBC-1013 (WH-1) is being developed for chronic wound treatment.
- Jun 2021Series C$64.4M
- Feb 2020Series B$11.6M
- 2016Series B$22.1M
#10
Seed · Kelvin Grove, Queensland · founded 2018 · 9 employees$2.2Mraised▾
Manufacturer of extracellular matrix for research purpose. The product Luna gel is a photocrosslinkable extracellular matrix based on chemically-modified pharmaceutical grade gelatin. It retains the intrinsic cell-instructive bioactivity of natural ECMs facilitating cell attachment, proliferation, differentiation, migration, and proteolytic degradation. It has applications in cell attachment and proliferation, stem cell culture and differentiation, mechanotransduction assays, cancer spheroid assays.
- Jul 2024Seed$2.2M
#11
Series A · Brisbane, Queensland · founded 2005 · 59 employees$7.5Mraised▾
Developer of magnetic resonance imaging devices for the diagnosis of multiple diseases. The company has developed multiple MRI devices by using proprietary technology such as superconducting magnets that help to deliver a more economical MRI system and can be used by clinicians, gradient coils, and radiofrequency coils that can be used in transcranial magnetic stimulation (TMS) and functional MRI studies.
- Dec 2022Series A$7.5M
#12
Series A · Brisbane, Queensland · founded 2018 · 35 employees$5Mraised▾
Developer of wearable sensor technology for real-time personal health monitoring. The company focuses on creating microwearable sensors that capture data from the body's bio-signals. These sensors allow for the detection and treatment of health issues. The initial product is a hydration microwearable sensor designed for continuous monitoring. The technology aims to improve physical and mental performance through advanced machine learning.
- Nov 2022Series A$5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Queensland is moving
A read on the academic research around Biotechnology in Queensland — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 109 papers.
- The University of Queensland63
- University of Queensland20
- Queensland University of Technology17
- University of Southern Queensland6
- Central Queensland University5
- Gene expression3
- Chinese hamster ovary cell2
- Cell culture2
- Monoclonal antibody2
- Gene2
- In vivo3
- Selection (genetic algorithm)3
- Gene3
- Metagenomics2
- Sustainability2
- Agriculture3
- Population3
- Integrated pest management3
- Synthetic biology3
- Resistance (ecology)2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.